LXH-1211

N/A

Report date: 2025/09/28 11:10:41
NME

Base Information

Drug NameLXH-1211
Drug Alias NameLXH-12119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase activatorsAMP-activated protein kinases inhibitors
TargetsSoluble guanylate cyclaseAMP-activated protein kinases
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCentral South UniversityShandong Xinhua Pharmaceutical Company Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Xinhua Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A